If the batch numbers do not match across documents, or if the documents look like they were generated by different laboratories, that is a red flag
NICE guidance (NG28) recommends GLP-1 receptor agonists for type 2 diabetes in specific clinical circumstances, typically when metformin and other treatments have not achieved glycaemic targets
Lack of quality control: Since compounded drugs are not subject to the same rigorous FDA standards as commercially available drugs, their quality and potency can be inconsistent.Side effects of compounded drugs can include potential contamination due to poor compounding practices, incorrect dosage due to mixing errors, allergic reactions to added ingredients, and severe adverse events like infections, depending on the specific drug and compounding process, as compounded medications are not subject to the same rigorous FDA regulations as commercially available drugs
Frequently asked questions Is the semaglutide glycine B12 blend FDA approved
The concern is prolonged exposure to direct sunlight or fluorescent lighting